Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07709312 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients

StatusNot Yet Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Oct 15, 2026 → Jan 15, 2027
See other at-risk trials from Ain Shams University

Record History

  1. Start date: Jul 15, 2026 to Oct 15, 2026 Primary and study completion pushed from Oct 15, 2026 to Jan 15, 2027 · Eligibility criteria revised · Secondary endpoints: details revised at 2 of 3 entries Show 3 more changesShow less
    • Primary and study completion pushed from Oct 15, 2026 to Jan 15, 2027
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 2 of 3 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
this study aims to measure The Effect of Gingko Biloba on the Clinical Outcome of Rheumatoid Arthritis Patients ,the outcomes are hsCRp,calprotectin,DAS-28,HAQ-DI
Trial Details
NCT Number NCT07709312
Lead Sponsor Ain Shams University
Conditions Rheumatoid Arthritis (RA), Manegmentof Rheumatoid Arthritis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov